Why the long arc from cult(ure) to clinic matters in how we understand mind, wellbeing, and collective meaning-making.
The Arding Rooms, nestled in an energetic quarter of South West London, is a place where creative sparks find fertile ground. Its open interiors and cultural programming cultivate an ethos of thoughtful exchange – ideal for a topic that straddles humanities, science, and lived experience. Against this backdrop, the event “Cult To Clinic” invited people not only to listen but to question underlying assumptions about altered states, collective rituals, and the ethics of therapeutic power.
At the helm of the historical lens was Luca Mitchell, an art historian who asks a deceptively simple question: how have human societies portrayed and understood altered states across time? Mitchell’s work moves fluidly between Renaissance depictions of sacred experience and the ancient iconographies that hint at a long, deep relationship between art, ritual, and substances that alter consciousness.
His scholarship and curatorial projects (shaped by training at the Courtauld Institute and collaborations with major cultural institutions) give him a rare vantage point – one that reads visual culture as a kind of collective memory of human encounter with the unexplained, the divine, and the mind-bending. His presence in the programme anchored the “ancient cults” portion of the narrative, less as romanticised folklore and more as evidence of how spiritual experience and social structure have long interlocked around practices that we today describe as “psychedelic.”
On the scientific end stood Dr Rayyan Zafar, a postdoctoral fellow at Imperial College London’s Centre for Psychedelic Research and Neuropsychopharmacology. Zafar’s research sits at the heart of contemporary efforts to bring psychedelics into rigorous, ethical clinical spaces. His work explores mechanisms of brain function and dysfunction, with a particular focus on how compounds like psilocybin may be integrated into treatments for mental health and addiction. He currently leads pioneering studies including research into psilocybin-assisted therapy for gambling addiction, expanding the psychedelic clinical agenda beyond mood disorders alone.
Unlike broad popular narratives that swing between uncritical advocacy and dystopian warnings, Zafar’s work emphasises empirical nuance – safety profiles, neural imaging, ethical boundaries, and the complexities of translating subjective experience into measurable clinical outcomes. Mitchell and Zafar embodied the two poles of the event’s arc: historical imagination and clinical future, illustrating the ways in which history frames where modern science decides to open its doors.
Abstract Anecdotes And Emerging Evidence
The event challenged a common binary that sees ancient ritual and contemporary medicine as wholly separate. Instead, it presented psychedelics as a thread beginning with early human engagement in altered experience, and continuing through spiritual traditions, counterculture, and onto peer-reviewed clinical research. This demonstrated how contextual continuity and stories from the past shape modern imaginations and research questions.
Implicit in the story from “cult” to “clinic” is a shift in how authority operates. Ancient rituals often embedded substances in communal and cosmological frameworks. Modern clinics situate them in evidence, consent, and therapeutic standards. The gap between these modes isn’t merely regulatory, it’s ethical. Who holds interpretive authority over experience? How do we prevent suggestibility from morphing into undue influence? These questions are now front-and-centre in the field.
One of the most urgent insights of the evening was that psychedelics force us to reconsider where psychology ends and spirituality begins. Neuroscience maps neural circuits and historians trace symbols and myths; But both converge on the shared terrain of human meaning-making. The dialogue suggested that any robust understanding of psychedelics must acknowledge both neuronal detail and cultural scale.
Clinical trials are burgeoning, from PTSD to existential distress in palliative care, depression and addiction. Yet the event underscored how much remains uncertain. The psychedelic renaissance isn’t a linear progression – it’s a complex negotiation between hope, hype, history, and harm. The narrative arc from ancient cults to modern clinics reveals not a triumph, but a recalibration of values, evidence, and cultural imagination.
What emerged most vividly wasn’t a single conclusion so much as a productive tension. History warns against uncritical celebration; science cautions against romanticism. In stitching these registers together, the event invited us to think not just about substances, but about ways of knowing – how collective practices, cultural narratives, and rigorous evidence shape what we call healing. If psychedelics are, in some sense, gateways – this event was about what we bring with us through those gateways: curiosity, scepticism, and a willingness to hold multiple interpretations in play at once.
